Quetiapine versus haloperidol decanoate for long-term treatment of schizophrenia and schizoaffective disorder

被引：0
|
作者：
Glick, I [1 ]
Marder, SR [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [21] LONG-TERM CLINICAL-EVALUATION OF HALOPERIDOL DECANOATE
    ERMENTINI, A
    MARINI, S
    FAZZARI, G
    ARMINIO, M
    BOSIO, A
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 540 - 541
  • [22] The comparison of risperidone, olanzapine and quetiapine in the treatment of chronic schizophrenia and schizoaffective disorder
    Kim, JG
    Cho, DH
    Choi, HK
    Kim, HJ
    Cho, JH
    Kang, SH
    Lee, SJ
    Lee, JG
    Kim, HT
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S245 - S245
  • [23] Weight gain in patients with schizophrenia and schizoaffective disorder induced by the long-term treatment with atypical antipsychotics
    Gorobets, I. N.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, 108 (09) : 52 - +
  • [24] Long-term treatment with quetiapine improves cognitive function in schizophrenia
    Purdon, SE
    Malla, A
    Labelle, A
    Litt, W
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 42S - 42S
  • [25] Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
    Kane, JM
    Carson, WH
    Saha, AR
    McQuade, RD
    Ingenito, GG
    Zimbroff, DL
    Ali, MW
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (09) : 763 - 771
  • [26] RELAPSE PREVENTION IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER WITH RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE: RANDOMIZED, LONG-TERM, OPEN-LABEL, CLINICAL TRIAL RESULTS (CONSTATRE)
    Gaebel, W.
    Bergmans, P.
    de Arce, R.
    Rouillon, F.
    Cordes, J.
    Eriksson, L.
    Schreiner, A.
    Smeraldi, E.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [27] Iloperidone is effective and well tolerated in the long term treatment of schizophrenia and schizoaffective disorder
    Fairweather, DB
    Young, F
    Zaninelli, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S277 - S278
  • [28] Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
    Pinna, Federica
    Sanna, Lucia
    Perra, Valeria
    Randaccio, Rachele Pisu
    Diana, Enrica
    Carpiniello, Bernard
    RIVISTA DI PSICHIATRIA, 2014, 49 (01) : 41 - 49
  • [29] Influence of long-term quetiapine (seroquel) and haloperidol therapy on cognitive deficit in patients with paranoid schizophrenia
    Mosolov, SN
    Kabanov, SO
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2004, 104 (06): : 27 - 34
  • [30] Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
    Volavka, J
    Czobor, P
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, JP
    Cooper, TB
    Chakos, M
    Lieberman, JA
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (02): : 255 - 262
12345